Inventor · disambiguated record
Yves Fradet
Also filed as: FRADET YVES
13 granted patents·8 pending applications·109 citations·filing 1983–2022
92Inventor score
Top patents by PatentIndex Score
21 records- 0192US8987423B2MAGE antigen binding proteinsBERGERON ALAIN·Filed 2011·Granted Mar 24, 2015·22 cites·9 claims
- 0290US8192931B2Method to detect prostate cancer in a sampleFRADET YVES·Filed 2009·Granted Jun 5, 2012·20 cites·19 claims
- 0388US7368545B1PCA3 messenger RNA species in benign and malignant prostate tissuesDIAGNOCURE INC·Filed 2000·Granted May 6, 2008·23 cites·21 claims
- 0486US7927806B2Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissuesDIAGNOCURE INC·Filed 2009·Granted Apr 19, 2011·6 cites·20 claims
- 0584US7655408B2PCA3 messenger RNA species in benign and malignant prostate tissuesDIAGNOCURE INC·Filed 2008·Granted Feb 2, 2010·5 cites·16 claims
- 0683US8241848B2Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissuesBUSSE URSULA·Filed 2011·Granted Aug 14, 2012·5 cites·17 claims
- 0778US10006092B2Method to detect prostate cancer in a sampleGEN PROBE INC·Filed 2016·Granted Jun 26, 2018·1 cites·20 claims
- 0877US8546551B2Method to detect prostate cancer in a sampleFRADET YVES·Filed 2012·Granted Oct 1, 2013·1 cites·17 claims
- 0973US8618276B2Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissuesBUSSE URSULA·Filed 2012·Granted Dec 31, 2013·1 cites·24 claims
- 1071US11104958B2Method to detect prostate cancer in a sampleGEN PROBE INC·Filed 2018·Granted Aug 31, 2021·0 cites·20 claims
- 1168US2013344487A1Method to detect prostate cancer in a sampleDIAGNOCURE INC·Filed 2013·Application pending·0 cites
- 1264US2005282170A1Method to detect prostate cancer in a sampleDIAGNOCURE INC·Filed 2004·Application pending·0 cites
- 1364US2018171416A1Distinguishing pca3 messenger rna species in benign and malignant prostate tissuesGEN PROBE INC·Filed 2018·Application pending·0 cites
- 1462US2014087384A1Distinguishing pca3 messenger rna species in benign and malignant prostate tissuesDIAGNOCURE INC·Filed 2013·Application pending·0 cites
- 1561US9909189B2Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissuesGEN PROBE INC·Filed 2015·Granted Mar 6, 2018·0 cites·18 claims
- 1661US2024390468A1Survivin and mage-a9 dual-targeted immunotherapyIMMUNOVACCINE TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1760US4643971AMonoclonal antibodies to human bladder and ureter cancers and methodSLOAN KETTERING INST CANCER·Filed 1983·Granted Feb 17, 1987·17 cites·10 claims
- 1851US5039611AMonoclonal antibodies to superficial papillary bladder tumor cellsUNIV LAVAL·Filed 1987·Granted Aug 13, 1991·8 cites·3 claims
- 1946US2009028888A1Cancer Antigen Mage-A9 and Uses ThereofBERGERON ALAIN·Filed 2006·Application pending·0 cites
- 2043US2015218646A1Methods, kits and compositions for providing a clinical assessment of prostate cancerDIAGNOCURE INC·Filed 2013·Application pending·0 cites
- 2139US2013149703A1"markers for prostate cancer progression"LEVESQUE ERIC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yves Fradet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →